Nicergoline [Regulatives / Guidelines]

posted by ioanam – Romania, 2013-09-07 23:55 (4672 d 03:17 ago) – Posting: # 11461
Views: 4,144
(edited on 2013-09-09 10:15)

Dear all,

I have a question about a bioequivalence study for nicergoline.

Nicergoline is not quantifiable in plasma, but both metabolites MMDL and MDL are detectable. According to EMA regulation, which of the metabolites should be analyzed?
My opinion is that for both of them must be performed the statistics. Am I wrong?

Thank you for advice.

Ioana


Edit: Category changed. [Dr_Dan]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
129 visitors (0 registered, 129 guests [including 29 identified bots]).
Forum time: 03:12 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5